Teva Recalls 580,000 Blood Pressure Pills Over Cancer Risk

Teva Pharmaceuticals USA has voluntarily recalled more than 580,000 bottles of prazosin hydrochloride capsules, a medication used to treat high blood pressure and PTSD-related symptoms, due to the presence of nitrosamine impurities, which are potentially cancer-causing chemicals. The FDA has classified the recall as Class II, indicating that the medication could cause temporary or medically reversible adverse health effects, though the risk of serious harm is considered remote. Patients are advised to check their medication lot numbers against the recall list, available on the FDA website, and consult their healthcare providers to discuss alternatives or concerns. The recalled impurity, identified as N-nitroso Prazosin impurity C, has raised concerns given its potential cancer risk if consumed long term. Pharmacies and distributors have been instructed to halt distribution, and affected patients are urged to contact medical professionals for guidance. This recall adds to previous concerns over nitrosamine impurities found in other blood pressure medications.